Endpoints News ١٦ ديسمبر ٢٠٢٥ Nektar's immunology drug misses in Phase 2b, execs cite enrollment errors
Endpoints News ١٦ ديسمبر ٢٠٢٥ J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell
Endpoints News ١٦ ديسمبر ٢٠٢٥ OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ
Endpoints News ١٦ ديسمبر ٢٠٢٥ Chronic pain biotech Ambros Therapeutics emerges with $125M and Vivek Ramaswamy on board
Endpoints News ١٦ ديسمبر ٢٠٢٥ Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity
Endpoints News ١٥ ديسمبر ٢٠٢٥ FDA wants to use more real-world data and calls again for early-phase trials reform
Endpoints News ١٥ ديسمبر ٢٠٢٥ Enhertu combo wins FDA approval for first-line use in metastatic breast cancer
Endpoints News ١٥ ديسمبر ٢٠٢٥ FDA speeds up review of J&J's multiple myeloma combo treatment following positive data
Endpoints News ١٥ ديسمبر ٢٠٢٥ With GLP-1 microdoses, Noom targets lower-BMI group outside FDA obesity drug labels
Endpoints News ١٥ ديسمبر ٢٠٢٥ Aviceda's geographic atrophy drug fails mid-stage study. Can it do better in Phase 3?
Endpoints News ١٥ ديسمبر ٢٠٢٥ Areteia Therapeutics to wind down after terminating Phase 3 asthma studies